The Pathobiology and Pathoimmunology of Neurodegeneration and Inflammation in MS: Immune Mechanisms, Axonal Repair, and Strategies Aimed at Neuroprotection Thomas P. Leist, MD, PhD – Program Chair
Novel Oral, Neuroimmunomodulating Agents: Effects on Inflammatory, Neuroprotective, Disability, and Clinical Outcomes in MS Daniel Kantor, MD
MS Master Forum Faculty, Regional Experts’ Panel, and Neurologist/MS Specialists Group Discussion, Q&A, and Data Analysis: Faculty Panel
Matching Therapy to MS Mechanisms: Unique Solutions for Unique Patients Thomas P. Leist, MD, PhD – Program Chair
MS Master Forum Faculty, Regional Experts’ Panel, and Neurologist/MS Specialists Group Discussion, Q&A, and Data Analysis Faculty Panel
Oral Agents - Current and Future Leslie P. Weiner, MD
Case Studies and Clinical Decision Tree-Analysis for Oral-Based Management of Multiple Sclerosis Faculty Panel
